Sleep Last reviewed: June 7, 2026

Is melatonin safe for long-term use?

Moderate Evidence
Confidence Score 60%
โš–๏ธ

IT DEPENDS

Moderate evidence suggests melatonin is safe for short-to-medium term use (up to 3-6 months) with minimal side effects. Long-term safety data (>1 year) is limited but available studies show no major concerns.

The Verdict

Moderate evidence suggests melatonin is safe for short-to-medium term use (up to 3-6 months) with minimal side effects. Long-term safety data (>1 year) is limited but available studies show no major concerns.

What the Evidence Shows

Melatonin is a hormone naturally produced by the pineal gland that regulates the sleep-wake cycle. As a supplement, it's been used for decades with a strong short-term safety profile. RCTs lasting up to 6 months consistently report side effects comparable to placebo โ€” occasional headache, dizziness, and daytime drowsiness at higher doses. Unlike pharmaceutical sleep aids, melatonin does not appear to cause dependence, tolerance, or withdrawal. Studies in blind individuals using melatonin for years show no apparent long-term adverse effects. However, rigorous long-term RCTs (>1 year) specifically designed to assess safety are lacking. Concerns about exogenous melatonin suppressing endogenous production have not been confirmed in human studies at standard doses (0.5-5mg). In children, the evidence is more cautious due to theoretical effects on puberty, though current data does not support this concern.

Evidence Quality

3

Meta-Analyses

35

RCTs

15

Observational

Important Caveats

  • โš ๏ธ Long-term RCTs (>1 year) specifically designed for safety outcomes are limited
  • โš ๏ธ Supplement quality varies significantly โ€” studies show label accuracy issues (ยฑ83% of listed dose)
  • โš ๏ธ Higher doses (>5mg) may cause daytime drowsiness and are likely unnecessary
  • โš ๏ธ Timing matters more than dose โ€” take 30-60 minutes before desired sleep time
  • โš ๏ธ Use in children is debated; generally considered safe but should involve a pediatrician
  • โš ๏ธ Not regulated as a drug in most countries, so quality control varies

Population Studied

Adults of all ages; separate studies in elderly (most common use), shift workers, jet lag sufferers, blind individuals, and children with ADHD/ASD

Dosage

Effective dose: 0.5-3mg for most adults (lower than many commercial products). Higher doses don't improve efficacy and increase side effects

Duration

Short-term safety well-established (up to 6 months). Limited but reassuring data up to 3.5 years in blind populations

Supporting Studies (2)

Meta-analysis: melatonin for the treatment of primary sleep disorders

Meta-Analysis

Ferracioli-Oda E, Qawasmi A, Bloch MH. ยท PLoS ONE (2013)

Melatonin reduced sleep onset latency by 7 minutes, increased total sleep time by 8 minutes, and improved sleep quality. No significant adverse effects compared to placebo across 19 RCTs.

View paper (DOI) โ†’

Prolonged-release melatonin for insomnia: long-term safety in elderly patients

RCT

Lemoine P, Nir T, Laudon M, et al. ยท Journal of Clinical Sleep Medicine (2012)

Prolonged-release melatonin (2mg) used for 12 months in elderly patients showed no withdrawal effects, rebound insomnia, or safety concerns upon discontinuation.

View paper (DOI) โ†’

Contradicting Studies (1)

Melatonin supplement quality: how much do products deviate from the label?

Observational

Erland LA, Saxena PK. ยท Journal of Clinical Sleep Medicine (2017)

Of 31 melatonin supplements tested, actual melatonin content ranged from -83% to +478% of the labeled amount. Some contained serotonin, which was not listed. This raises safety concerns about what consumers are actually taking.

Why this disagrees:

While melatonin itself appears safe, the lack of supplement regulation means consumers may be taking wildly different doses than intended, or contaminated products. The safety data from clinical trials may not apply to poorly manufactured commercial supplements.

View paper (DOI) โ†’
Share:
Was this helpful?

Related Claims